FDA Approves Budesonide/Formoterol Fumarate Dihydrate for COPD – DG News
 SYS-CON Media | FDA Approves Budesonide/Formoterol Fumarate Dihydrate for COPD DG News The approval is based on results from 2 pivotal phase 3 trials that evaluated more than 3600 patients aged 40 years and older with moderate to very severe COPD. The studies demonstrated that patients using budesonide/formoterol fumarate dihydrate ... AstraZeneca reveals FDA Approval For SYMBICORT - Update RTT News AstraZeneca wins new approval for asthma inhaler Forbes all 29 news articles |